Skip to main content Accessibility help
×
Home

Use of Active Surveillance Cultures to Detect Asymptomatic Colonization With Carbapenem-Resistant Klebsiella pneumoniae in Intensive Care Unit Patients

  • David Calfee (a1) and Stephen G. Jenkins (a2)

Abstract

Carbapenem-resistant Klebsiella pneumoniae is emerging as a significant healthcare-associated pathogen. Clinical cultures detect only a fraction of the colonized population, and patients with asymptomatic colonization are at risk of invasive infection. Additional study of the impact of detection of asymptomatic colonization on subsequent infection and transmission is needed.

Copyright

Corresponding author

Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1151, New York, NY 10029 (david.calfee@mountsinai.org)

References

Hide All
1.Bradford, P, Bratu, S, Urban, C, et al.Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 B-lactamases in New York City. Clin Infect Dis 2004;39:5560.
2.Bratu, S, Landman, D, Haag, R, et al.Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:14301435.
3.Bratu, S, Mooty, M, Nichani, S, et al.Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 2005;49:30183020.
4.Schwaber, M, Klarfeld-Lidji, S, Navon-Venezia, S, Schwartz, D, Leavitt, A, Carmeli, Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults, and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:102833.
5.Kuhar, D, Calfee, D. Risk factors for colonization and/or infection with carbapenem-resistant Klebsiella pneumoniae (CRKP). In: Program and abstracts of the 17th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; 2007; Baltimore, MD. Alexandria, VA: Society for Healthcare Epidemiology of America; 2007:130. Abstract 250.
6.Falagas, M, Rafailidis, P, Kofteridis, D, et al.Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case-control study. J Antimicrob Chemother 2007;60:11241130.
7.Patel, G, Huprikar, S, Jenkins, S, Calfee, D. Carbapenem-resistant Klebsiella pneumoniae: risk factors and mortality. In: Program and abstracts of the 45th Annual Meeting of the Infectious Diseases Society of America; October 2007; San Diego, CA. Arlington, VA: Infectious Diseases Society of America; 2007:59. Abstract 563.
8.Bratu, S, Landman, D, Alam, M, Tolentino, E, Quale, J. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob Agents Chemother 2005;49:776778.
9.Bratu, S, Brooks, S, Burney, S, et al.Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin Infect Dis 2007;44:972975.
10.Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibilities testing: 16th informational supplement. CLSI document. Wayne, PA: CLSI, 2006:M100S16.
11.Landman, D, Salvani, J, Bratu, S, Quale, J. Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures. J Clin Microbiol 2005;43:56395641.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed